Tenet to Participate in the Barclays 28th Annual Global Healthcare Conference
Business Wire (Wed, 4-Mar 9:00 AM ET)
Market Chameleon (Wed, 11-Feb 3:33 AM ET)
Tenet Reports Strong Fourth Quarter and FY 2025 Results; Provides 2026 Financial Outlook
Business Wire (Wed, 11-Feb 6:45 AM ET)
Tenet Announces Accretive Transaction and Previews Strong 2025 Results
Business Wire (Mon, 2-Feb 6:45 AM ET)
Tenet to Report its Fourth Quarter 2025 Results on February 11th
Business Wire (Wed, 7-Jan 9:00 AM ET)
THC Call Spread Trade Totals $445K With 10.7% Gain in One Hour—Are Technicals and Skew Aligned?
Market Chameleon (Wed, 20-Aug 7:09 AM ET)
THC Call Spread Volume Hits $933K—Buyers Target $1.4M Upside Amid Technical Strength
Market Chameleon (Tue, 19-Aug 10:09 AM ET)
Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (50 as of December 2025) and hundreds of ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
Tenet Healthcare trades on the NYSE stock market under the symbol THC.
As of March 20, 2026, THC stock price declined to $200.35 with 1,539,347 million shares trading.
THC has a beta of 1.03, meaning it tends to be more sensitive to market movements. THC has a correlation of 0.18 to the broad based SPY ETF.
THC has a market cap of $17.61 billion. This is considered a Large Cap stock.
Last quarter Tenet Healthcare reported $6 billion in Revenue and $4.70 earnings per share. This beat revenue expectation by $64 million and exceeded earnings estimates by $.64.
In the last 3 years, THC traded as high as $247.21 and as low as $51.04.
The top ETF exchange traded funds that THC belongs to (by Net Assets): VTI, IJH, VB, VBR, VXF.
THC has outperformed the market in the last year with a return of +56.8%, while the SPY ETF gained +15.6%. In the last 3 month period, THC beat the market returning +2.0%, while SPY returned -4.7%. However, in the most recent 2 weeks THC has underperformed the stock market by returning -17.0%, while SPY returned -4.8%.
THC support price is $199.33 and resistance is $210.89 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that THC shares will trade within this expected range on the day.
